Global Cell Therapy Bioprocessing Market Report 2021-2028: Digital Biomanufacturing to Gain Prominence
03 juin 2021 05h58 HE
|
Research and Markets
Dublin, June 03, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Bioprocessing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology, Cell Type, End User, and Geography" report has...
Intellia Therapeutics Announces First Quarter 2021 Financial Results
06 mai 2021 07h30 HE
|
Intellia Therapeutics, Inc.
Plan to report initial safety and activity data from Phase 1 study of NTLA-2001, a potentially curative single-dose therapy for transthyretin amyloidosis (ATTR), in mid-2021 On track to submit an IND...
Outlook on the Cell Therapy Global Market to 2027 - by Therapy Type, Product, Technology, Application, End-user and Geography
31 mars 2021 05h18 HE
|
Research and Markets
Dublin, March 31, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Therapy Type; Product; Technology; Application; End User, and Geography"...
Intellia Therapeutics’ Investigational CRISPR Treatment NTLA-2001 Receives European Union Orphan Drug Designation for ATTR Amyloidosis
30 mars 2021 07h30 HE
|
Intellia Therapeutics, Inc.
CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9...
Global Precision Medicine Market (2021 to 2028) - Demand for Preventive Care Presents Opportunities
25 mars 2021 08h13 HE
|
Research and Markets
Dublin, March 25, 2021 (GLOBE NEWSWIRE) -- The "Global Precision Medicine Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The publisher predicts that the global market...
Intellia Therapeutics Presents New Data on Expanded Cell Engineering Capabilities Utilizing Base Editors
25 mars 2021 07h30 HE
|
Intellia Therapeutics, Inc.
CAMBRIDGE, Mass., March 25, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA) will present the first preclinical data set on its novel cytosine deaminase base editor technology at...
North America Digital Genome Market Report 2021: Continuous Funding by the Manufacturers and Government in the Field of Genomics - Forecast to 2028
15 mars 2021 06h03 HE
|
Research and Markets
Dublin, March 15, 2021 (GLOBE NEWSWIRE) -- The "North America Digital Genome Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. North America market for digital genome is...
Outlook on the Cell Therapy Biomanufacturing Global Market to 2025 - by Product Type, Application and Region
22 févr. 2021 06h48 HE
|
Research and Markets
Dublin, Feb. 22, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Biomanufacturing: Global Markets" report has been added to ResearchAndMarkets.com's offering. This research report presents an in-depth...
Global Gene Therapy Market Outlook to 2030 - by Therapeutic Approach, Type of Gene Therapy, Type of Vectors Used, Therapeutic Areas, Route of Administration and Key Geographical Regions
15 févr. 2021 07h03 HE
|
Research and Markets
Dublin, Feb. 15, 2021 (GLOBE NEWSWIRE) -- The "Gene Therapy Market by Therapeutic Approach, Type of Gene Therapy, Type of Vectors Used, Therapeutic Areas, Route of Administration, and Key...
Outlook on the CRISPR Gene Editing Global Market to 2030 - Analysis and Forecasts
08 févr. 2021 07h33 HE
|
Research and Markets
Dublin, Feb. 08, 2021 (GLOBE NEWSWIRE) -- The "Global CRISPR Gene Editing Market: Focus on Products, Applications, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and...